Interaction of cblA/adhesin-positive Burkholderia cepacia with squamous epithelium.
A highly transmissible strain of Burkholderia cepacia from genomovar III carries the cable pilin gene, expresses the 22 kDa adhesin (cblA +ve/Adh +ve), binds to cytokeratin 13 (CK13) and is invasive. CK13 is expressed abundantly in the airway epithelia of cystic fibrosis (CF) patients. We have now investigated whether binding of cblA +ve/Adh +ve B. cepacia to CK13 potentiates bacterial invasion and epithelial damage using bronchial epithelial cell cultures differentiated into either squamous (CK13-enriched) or mucociliary (CK13-deficient) epithelia. Three different B. cepacia isolates (cblA +ve/Adh +ve, cblA +ve/Adh -ve and cblA -ve/Adh -ve) showed minimal binding to mucociliary cultures, and did not invade or cause cell damage. In contrast, the cblA +ve/Adh +ve isolate, but not others, bound to CK13-expressing cells in squamous cultures, caused cytotoxicity and stimulated IL-8 release within 2 h. By 24 h, this isolate invaded and migrated across the squamous culture, causing moderate to severe epithelial damage. A specific antiadhesin antibody, which blocked the initial binding of the cblA +ve/Adh +ve isolate to CK13, significantly inhibited all the pathologic effects. Transmission electron microscopy of squamous cultures incubated with the cblA +ve/Adh +ve isolate, revealed bacteria on the surface surrounded by filopodia by 2 h, and within the cells in membrane-bound vesicles by 24 h. Bacteria were also observed free in the cytoplasm, surrounded by intermediate filaments containing CK13. These findings suggest that binding of B. cepacia to CK13 is an important initial event and that it promotes bacterial invasion and epithelial damage.
Sajjan
Umadevi
U
Departments of Structural Biology and Biochemistry, The Hospital for Sick Children, Toronto, Ontario, Canada. usajjan@sickkids.on.ca
Ackerley
Cameron
C
Forstner
Janet
J
D018829:Adhesins, Bacterial / Q000276:immunology / Q000378:metabolism*; D000907:Antibodies, Bacterial / Q000494:pharmacology; D001422:Bacterial Adhesion / Q000187:drug effects; D001980:Bronchi; D016956:Burkholderia cepacia / Q000302:isolation & purification / Q000378:metabolism*; D002454:Cell Differentiation; D002478:Cells, Cultured; D036781:Fimbriae Proteins; D006801:Humans; D016209:Interleukin-8 / Q000032:analysis; D007633:Keratins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism*; D008854:Microscopy, Electron; D020545:Respiratory Mucosa / Q000276:immunology / Q000378:metabolism* / Q000382:microbiology; D013997:Time Factors
D018829:Adhesins, Bacterial; D000907:Antibodies, Bacterial; D016209:Interleukin-8; D008565:Membrane Proteins; D036781:Fimbriae Proteins; D007633:Keratins